Skip to main content

Poly Medicure Ltd

Stage 3 · Topping · week 1

As of 16 Oct 2026, Poly Medicure is in Stage 3 — topping, where an uptrend loses steam, in its first week (since 15 Oct 2026). It closed at ₹1,594, 22.8% below its 52-week high and above its 200-day average, which is falling. In Health Care, 40.6% of stocks are in Stage 2.

Poly Medicure Limited engages in the manufacture and sale of medical devices in India and internationally. More about the company

₹1,593.8
+0.63% today
₹16,155 Cr · Mid cap
Market Neutral — FadingHealth Care 40.6% in Stage 2-7.4 pts / 20dHealth Care Equipment & Supplies 20.0%-20.0 pts

Pro read

Pro

Our read

Topping — the uptrend is tiring

Setup score

—

Momentum

Steady

Edge

—

Is POLYMED early, or has it already run? Pro answers that for every NSE stock, after every close.

Loading price chart…
vs 52W High
-22.8%
₹1,191.1 lo₹2,063.4 hi
22.8% below 52W high — weakening from peak
Stock is rolling over from its 52W high. Stage 3 distribution — new longs are high risk here.
Stage Maturity
Week 1
1w13w26w
Week 1 — early distribution
How long this stock has been in Stage 3 distribution. Longer tops often precede deeper Stage 4 declines.
vs 200 DMA
1.9%
200 DMA: ₹1,563.4 · sloping down
Stock is losing its 200 DMA. Once lost, it confirms Stage 4 risk. This is a major red flag for existing holders.
Rel Volume
0.28x
vs 50-day avg
Volume spikes on down days during Stage 3 signal distribution — institutions are exiting. A clear warning to avoid new longs.
Trend Health
↓
MA20 rolling over · -3.4% vs MA50 -0.8%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
-6.5%
3M
-5.2%
6M
+6.5%
YTD
-11.5%
1Y
-16.6%
Sector
Health Care
↓ Peaking
Stage 2%
40.6%
20d Δ
-7.4pp
1M return
-3.8%
3M return
-1.0%
Sector Stage-2 % · last 20 days
Sector has 67 Stage 2 leaders. See Health Care Stage 2 →
Industry
Health Care Equipment & Supplies
↓ Peaking
Stage 2%
20.0%
20d Δ
-20.0pp
1M return
+2.8%
3M return
-8.0%
Industry Stage-2 % · last 20 days
Industry has 2 Stage 2 leaders. See Health Care Equipment & Supplies Stage 2 →
Stage Cycle Timeline2023-07-20 → 2026-10-16
S2 16w
S2 46w
S4 44w
2023-07-202026-10-16
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 16w → S3 1w → S2 13w → S3 2w → S2 46w → S3 8w → S4 7w → S1 8w → S4 44w → S1 13w → S2 9w → S3 1w current
Total tracked: 168 weeks across 12 stage runs.
Scan Membership
Breakout Watch
Latest: 2026-08-10
2 appearances in last 60 days. First seen: 2024-03-05.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding — staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-16S3
Wk 1 · Vol 0.28x
2026-10-15S32→3
Wk 1 · Vol 0.31x
2026-10-14S2
Wk 10 · Vol 0.42x
2026-10-13S2
Wk 9 · Vol 0.48x
2026-10-12S2
Wk 9 · Vol 0.33x
2026-10-09S2
Wk 9 · Vol 0.54x
2026-10-08S2
Wk 9 · Vol 0.51x
2026-10-07S2
Wk 9 · Vol 0.71x
2026-10-06S2
Wk 8 · Vol 0.58x
2026-10-05S2
Wk 8 · Vol 0.79x
2026-10-01S2
Wk 8 · Vol 0.57x
2026-09-30S2
Wk 8 · Vol 0.74x
Sector Peers — Stage 2All →
BAFNAPH
wk 19 · 0.0% from hi
8.6
KILITCH
wk 3 · -11.6% from hi
8.4
LAURUSLABS
wk 26 · -0.4% from hi
7.8
KOPRAN
wk 20 · -6.8% from hi
7.4
ZIMLAB
wk 23 · -5.2% from hi
6.9
Moving averages & range
50 DMA
₹1,708.1
200 DMA
₹1,563.4
52W High
₹2,063.4
52W Low
₹1,191.1
5D Low
₹1,583.8
Resistance levels (recent highs)
20d High
₹1,726.6
60d High
₹1,869.4
120d High
₹1,869.4
250d High
₹2,063.4
Next resistance
+8.3%
to 20d High
P/E (TTM)
41.8
Forward 27.3
Earnings Growth (YoY)
-17.6%
Revenue +16.4%
Dividend Yield
0.22%
P/B 4.6
About this companyHealth Care· Health Care Equipment & Supplies

Poly Medicure Limited engages in the manufacture and sale of medical devices in India and internationally. The company offers infusion therapy products, such as I.V Infusion set, extension lines, needle free connector, I.V flow regulator extension set, burette set, three way stop cock, vial access spike, transfer spike, orburator, polyflush, maifolds, polyswab, and arterial blood collection; critical care products, including vial access spikes, arterial cannula, mini mid lines over the wire, extension line, enteral connector, central venous catheters, and huber needle; dialysis and renal care products, comprising peritoneal dialysis set, haemocent, standard and safety fistula needle, dialyzer, bloodlines and dialysis system. It also provides cardiology products PTFE wire, inflation device, Y-connector, manifold, introducer, IV Cannula, hydrophilic wire, guiding catheter, drug eluting stent, PTCA dilation catheter, diagnostic catheter, and electrocardiograph electrodes; vaccular access products; oncology products; diagnostics products, such as blood collection tubes, safety blood collection set, blood collection needles, and standard needle holder. In addition, the company offers transfusion system products, including blood bags, blood administration set, and others; anesthesia and respiratory care products, comprising variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, aerosol therapy masks, ventilator circuits, suction catheters, spinal needle, polyciser, oxygen catheter, nebulizer compressor system, twin bore nasal oxygen cannula mucus extractor, HME filter, oro-pharyngeal airways, endotracheal tubes, catheter mount, and brain circuit; urology products, including urine collection bags, leg bag set, irrigation sets, foley balloon and urine drainage catheters, and urine collection bags with measured volume meters; wound drainage; and gastroenterology products. The company was incorporated in 1995 and is based in New Delhi, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-16. Past data patterns are not indicative of future results. This page is a data analytics tool only.